These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 11059777

  • 1. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
    Ayyanathan K, Fredericks WJ, Berking C, Herlyn M, Balakrishnan C, Gunther E, Rauscher FJ.
    Cancer Res; 2000 Oct 15; 60(20):5803-14. PubMed ID: 11059777
    [Abstract] [Full Text] [Related]

  • 2. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ, Ayyanathan K, Herlyn M, Friedman JR, Rauscher FJ.
    Mol Cell Biol; 2000 Jul 15; 20(14):5019-31. PubMed ID: 10866659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE, Jeon IS, Shapiro DN.
    Oncogene; 1995 Aug 03; 11(3):545-52. PubMed ID: 7630639
    [Abstract] [Full Text] [Related]

  • 5. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M, Quon MJ, Maor G, Avigad S, Shapiro DN, Harel C, Esposito D, Goshen Y, Yaniv I, Karnieli E.
    J Clin Endocrinol Metab; 2002 Nov 03; 87(11):5312-24. PubMed ID: 12414908
    [Abstract] [Full Text] [Related]

  • 6. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
    Bennicelli JL, Edwards RH, Barr FG.
    Proc Natl Acad Sci U S A; 1996 May 28; 93(11):5455-9. PubMed ID: 8643596
    [Abstract] [Full Text] [Related]

  • 7. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
    Fredericks WJ, Galili N, Mukhopadhyay S, Rovera G, Bennicelli J, Barr FG, Rauscher FJ.
    Mol Cell Biol; 1995 Mar 28; 15(3):1522-35. PubMed ID: 7862145
    [Abstract] [Full Text] [Related]

  • 8. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG.
    Oncogene; 2001 Sep 10; 20(40):5736-46. PubMed ID: 11607823
    [Abstract] [Full Text] [Related]

  • 9. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R, Scuoppo C, Bersani F, Accornero P, Forni PE, Miretti S, Grinza A, Allegra P, Schmitt-Ney M, Crepaldi T, Ponzetto C.
    Cancer Res; 2006 May 01; 66(9):4742-9. PubMed ID: 16651427
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
    Xia SJ, Barr FG.
    Oncogene; 2004 Sep 09; 23(41):6864-71. PubMed ID: 15286710
    [Abstract] [Full Text] [Related]

  • 11. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
    Kempf BE, Vogt PK.
    Cell Growth Differ; 1999 Dec 09; 10(12):813-8. PubMed ID: 10616906
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
    Hu Q, Yuan Y, Wang C.
    PLoS One; 2013 Dec 09; 8(6):e68065. PubMed ID: 23799156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
    Keller C, Hansen MS, Coffin CM, Capecchi MR.
    Genes Dev; 2004 Nov 01; 18(21):2608-13. PubMed ID: 15520281
    [Abstract] [Full Text] [Related]

  • 20. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
    Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PH.
    Cancer Res; 2002 Aug 15; 62(16):4704-10. PubMed ID: 12183429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.